BNTX
BioNTech SENASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$25.12B
P/E Ratio
—
EPS
$-5.61
Beta
1.37
52W High
$124.00
52W Low
$79.52
50-Day MA
$97.43
200-Day MA
$102.56
Dividend Yield
—
Profit Margin
-39.60%
Forward P/E
161.29
PEG Ratio
0.05
About BioNTech SE
BioNTech SE, a biotechnology company, develops and markets immunotherapies for cancer and other infectious diseases. The company is headquartered in Mainz, Germany.
Fundamentals
| Revenue (TTM) | $2.87B |
| Gross Profit (TTM) | $2.26B |
| EBITDA | $-1.12B |
| Operating Margin | -33.40% |
| Return on Equity | -5.88% |
| Return on Assets | -3.56% |
| Revenue/Share (TTM) | $11.87 |
| Book Value | $89.71 |
| Price-to-Book | 1.09 |
| Price-to-Sales (TTM) | 8.75 |
| EV/Revenue | 2.244 |
| EV/EBITDA | 32.70 |
| Quarterly Earnings Growth (YoY) | -43.20% |
| Quarterly Revenue Growth (YoY) | -23.70% |
| Shares Outstanding | $252.88M |
| Float | $103.72M |
| % Insiders | 57.42% |
| % Institutions | 20.30% |
Historical Volatility
HV 10-Day
52.79%
HV 20-Day
43.41%
HV 30-Day
39.48%
HV 60-Day
57.90%
HV Rank
42.9%
Volatility is currently expanding
Analyst Ratings
Consensus ($130.48 target)
1
Strong Buy13
Buy5
HoldMore HEALTHCARE Stocks
Data last updated: 5/5/2026